Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

138
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
138
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

98
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
98
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

195
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
195
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

90
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
90
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

100
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
100
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

1.9K
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
1.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrating psychological care into atrial fibrillation management: insights from HOPE-AF.

European journal of cardiovascular nursing·2026
Same author

Comparative Analysis of Circulating Cytokines and Adrenergic Autoantibodies in Postural Orthostatic Tachycardia Syndrome, Postacute Sequelae of SARS-CoV-2, and Healthy Controls.

Journal of the American Heart Association·2026
Same author

Transseptal access with an electrified guidewire and large pulsed field ablation sheath.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2026
Same author

Have a heart: Evidence for a suicide problem in cardiology.

Journal of affective disorders·2026
Same author

Suicide prevention in patients with cardiovascular conditions.

BMJ (Clinical research ed.)·2026
Same author

Patient Perspectives on Multidisciplinary Management of Postural Orthostatic Tachycardia Syndrome (POTS): Insights from Real-World Experience.

European journal of cardiovascular nursing·2026

Related Experiment Video

Updated: Nov 9, 2025

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

33.6K

Risk factor management and atrial fibrillation.

Jeroen M Hendriks1,2, Celine Gallagher1, Melissa E Middeldorp1

  • 1Centre for Heart Rhythm Disorders, University of Adelaide and Royal Adelaide Hospital, Adelaide, Australia.

Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology
|April 10, 2021
PubMed
Summary

Managing atrial fibrillation (AF) now includes crucial risk factor management. Novel care models are emerging to comprehensively treat the growing AF population.

Keywords:
Atrial fibrillationIntegrated careMulti-morbidityRisk factor management

More Related Videos

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

84.1K
Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
08:10

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation

Published on: July 20, 2022

1.9K

Related Experiment Videos

Last Updated: Nov 9, 2025

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

33.6K
The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

84.1K
Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
08:10

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation

Published on: July 20, 2022

1.9K

Area of Science:

  • Cardiology and Cardiovascular Health
  • Public Health and Healthcare Management

Background:

  • Atrial fibrillation (AF) management has evolved significantly over the past century.
  • Traditional AF treatment focused solely on the arrhythmia, neglecting broader patient needs.
  • Risk factor management is now recognized as a fundamental component of effective AF care.

Purpose of the Study:

  • To review the evidence supporting risk factor management in atrial fibrillation.
  • To explore the integration and implementation of novel care delivery models for AF.
  • To identify research gaps and healthcare reform needs for comprehensive AF population management.

Main Methods:

  • Systematic review of current evidence on risk factor management in AF.
  • Analysis of emerging and novel models for comprehensive AF care delivery.
  • Identification of implementation strategies and barriers in clinical practice.

Main Results:

  • Strong evidence supports the critical role of risk factor management in improving AF outcomes.
  • Novel care delivery models demonstrate potential for more integrated and comprehensive AF patient management.
  • Implementation challenges exist but can be overcome with targeted strategies and healthcare reform.

Conclusions:

  • Comprehensive AF management necessitates a paradigm shift towards integrated risk factor control.
  • Novel care delivery systems are essential for effectively implementing these changes.
  • Further research and healthcare reform are needed to address the increasing burden of AF globally.